HK75195A - Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form - Google Patents
Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active formInfo
- Publication number
- HK75195A HK75195A HK75195A HK75195A HK75195A HK 75195 A HK75195 A HK 75195A HK 75195 A HK75195 A HK 75195A HK 75195 A HK75195 A HK 75195A HK 75195 A HK75195 A HK 75195A
- Authority
- HK
- Hong Kong
- Prior art keywords
- plasmid
- recovering
- expression
- active form
- superoxide dismutase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/446—Superoxide dismutase (1.15)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80109085A | 1985-11-22 | 1985-11-22 | |
US90705186A | 1986-09-12 | 1986-09-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK75195A true HK75195A (en) | 1995-05-26 |
Family
ID=27122291
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK75195A HK75195A (en) | 1985-11-22 | 1995-05-18 | Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form |
Country Status (21)
Country | Link |
---|---|
JP (2) | JP2609449B2 (en) |
AT (1) | AT400443B (en) |
AU (1) | AU607897B2 (en) |
BE (1) | BE905796A (en) |
CA (1) | CA1341362C (en) |
CH (1) | CH676990A5 (en) |
DE (1) | DE3639725C2 (en) |
DK (1) | DK534686A (en) |
ES (1) | ES2003518A6 (en) |
FI (1) | FI90353C (en) |
FR (1) | FR2590591B1 (en) |
GB (1) | GB2183658B (en) |
GR (1) | GR862713B (en) |
HK (1) | HK75195A (en) |
IE (1) | IE59498B1 (en) |
IL (2) | IL106449A (en) |
IT (1) | IT1205418B (en) |
LU (1) | LU86676A1 (en) |
NL (1) | NL8602960A (en) |
PT (1) | PT83792B (en) |
SE (1) | SE8604884L (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6610520B1 (en) | 1985-11-22 | 2003-08-26 | Bio-Technology General Corp. | Gene encoding human manganese superoxide dismutase and recombinant polypeptide encoded thereby |
JPS62215532A (en) * | 1986-03-18 | 1987-09-22 | Ube Ind Ltd | Anti-inflammatory drug |
JPH0643341B2 (en) * | 1986-03-27 | 1994-06-08 | 宇部興産株式会社 | Organ function improving agent |
JPH0643340B2 (en) * | 1986-09-03 | 1994-06-08 | 宇部興産株式会社 | Ischemic heart disease drug |
JPS6377822A (en) * | 1986-09-18 | 1988-04-08 | Ube Ind Ltd | Organ function improver |
US6326003B1 (en) | 1986-10-14 | 2001-12-04 | Chiron Corporation | Manganese superoxide dismutase cloning and expression in microorganisms |
EP0676472A1 (en) * | 1987-03-14 | 1995-10-11 | BOEHRINGER INGELHEIM INTERNATIONAL GmbH | Human manganese superoxide dismutase (hMn-SOD) |
US5260204A (en) * | 1987-03-14 | 1993-11-09 | Boehringer Ingelheim International Gmbh | Human manganese superoxide dismutase (hMn-SOD) |
ATE130196T1 (en) * | 1987-03-27 | 1995-12-15 | Bio Technology General Corp | HUMAN MANGANESE SUPEROXIDE DISMUTASE AND TREATMENT METHODS. |
JPH01233228A (en) * | 1988-03-11 | 1989-09-19 | Toyo Jozo Co Ltd | Metastasis preventive of malignant tumor cells |
US5772996A (en) * | 1990-08-03 | 1998-06-30 | Public Health Laboratory Service Board | Pharmaceutical compositions containing superoxide dismutase from Bacillus Stearothermophilus and Bacillus Caldotenax |
DE4038563A1 (en) * | 1990-12-04 | 1992-06-11 | Gruenenthal Gmbh | USE OF SUPEROXIDE DISMUTASES FOR PROPHYLAXIS AND / OR TREATMENT OF ORGAN FAILURE IN RISK PATIENTS WITH POLYTRAUMA |
DK0587055T3 (en) * | 1992-09-09 | 2002-04-02 | Bio Technology General Corp | Use of manganese superoxide dismutase (Mn-SOD) in the manufacture of drugs for the treatment of low-dose diseases |
DE4239877C1 (en) * | 1992-11-27 | 1994-03-17 | Boehringer Ingelheim Int | Stabilized superoxide dismutase (SOD) composition |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS56102787A (en) * | 1980-01-18 | 1981-08-17 | Mamoru Sugiura | Preparation of human placenta superoxide dismutase |
BG49718A3 (en) * | 1983-07-15 | 1992-01-15 | Bio- Technology General Corp | Method for preparing of polypeptid with superoxiddismutasne activitty |
DE3486493T2 (en) * | 1983-10-03 | 2003-05-22 | Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville | Cloning of superoxide dismutase and expression in microorganisms |
-
1986
- 1986-10-29 IE IE285186A patent/IE59498B1/en not_active IP Right Cessation
- 1986-11-07 DK DK534686A patent/DK534686A/en not_active Application Discontinuation
- 1986-11-10 AU AU64975/86A patent/AU607897B2/en not_active Ceased
- 1986-11-13 GR GR862713A patent/GR862713B/en unknown
- 1986-11-14 GB GB8627294A patent/GB2183658B/en not_active Expired - Fee Related
- 1986-11-14 SE SE8604884A patent/SE8604884L/en not_active Application Discontinuation
- 1986-11-18 ES ES8603083A patent/ES2003518A6/en not_active Expired
- 1986-11-19 AT AT0308986A patent/AT400443B/en not_active IP Right Cessation
- 1986-11-20 LU LU86676A patent/LU86676A1/en unknown
- 1986-11-20 BE BE0/217445A patent/BE905796A/en not_active IP Right Cessation
- 1986-11-20 IL IL10644986A patent/IL106449A/en active IP Right Grant
- 1986-11-20 IL IL80702A patent/IL80702A0/en unknown
- 1986-11-21 DE DE3639725A patent/DE3639725C2/en not_active Expired - Fee Related
- 1986-11-21 JP JP61278528A patent/JP2609449B2/en not_active Expired - Lifetime
- 1986-11-21 FR FR868616238A patent/FR2590591B1/en not_active Expired
- 1986-11-21 CH CH4680/86A patent/CH676990A5/de not_active IP Right Cessation
- 1986-11-21 IT IT67865/86A patent/IT1205418B/en active
- 1986-11-21 NL NL8602960A patent/NL8602960A/en active Search and Examination
- 1986-11-21 PT PT83792A patent/PT83792B/en not_active IP Right Cessation
- 1986-11-21 CA CA000523536A patent/CA1341362C/en not_active Expired - Lifetime
- 1986-11-21 FI FI864756A patent/FI90353C/en not_active IP Right Cessation
-
1995
- 1995-05-18 HK HK75195A patent/HK75195A/en not_active IP Right Cessation
-
1996
- 1996-01-22 JP JP8008627A patent/JP2967557B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK75195A (en) | Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form | |
EP0190736A3 (en) | Chemical derivatives of ghl-cu | |
PH24833A (en) | Ascorbic acid derivatives and pharmaceutical composition thereof | |
NZ223227A (en) | Phosphinothricin-resistance gene active in plants and its use | |
CS938286A2 (en) | Fungicide and method of active substances production | |
IL74804A0 (en) | Human physiologically active polypeptide,its production and pharmaceutical compositions containing it | |
GR861717B (en) | Modified enzymes production and use thereof | |
DE3664119D1 (en) | Castor wheel and method of manufacture | |
AU6351186A (en) | Pharmaceutical composition comprising 1-hydroxy-2-pyridone and method for the treatment of acne | |
GB8719191D0 (en) | Improvements in and relating to target track assessment | |
PT83301B (en) | Expression of superoxide dismutase in eukaryotic cells and process for obtaining the same | |
DE3661878D1 (en) | Tobacco composition containing apocynum venetum or an extract thereof, and process to prepare it | |
DE3665853D1 (en) | Active carbon and process for its manufacture | |
ZA868610B (en) | Human manganese superoxide dismutase cdna,its expression in bacteria and method of recovering enzymatically active human manganese superoxide dismutase | |
ZA882272B (en) | Immunogenic recombinant yeast expression product and method for purifying it | |
IL80587A0 (en) | Alpha-(aminoalkyl)-arylacetic acid derivatives and their preparation | |
PT79810A (en) | Expression of human alpha-1-antitrysin in yeast | |
IL120245A0 (en) | Enzymatically active analogs and mutants of human manganese superoxide dismutase | |
GB2172704B (en) | Antigenically active protein and its use in the diagnosis of gonorrhoea | |
AU1763188A (en) | Recovery of proteins in active form | |
AU4864885A (en) | Medicinal composition and method of treatment of periarthritis and similar diseases | |
GB2177638B (en) | Improvements in and relating to welding. | |
IE881466L (en) | Ascorbic acid intermediates and process enzymes | |
AU5012185A (en) | Ascorbic acid derivatives and processes | |
PH24284A (en) | Method and composition for reducing blood cholesterol in humans or animals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |